| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T160 |
0-104 |
Sentence |
denotes |
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 |
| T1 |
0-104 |
Sentence |
denotes |
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 |
| T2 |
107-115 |
Sentence |
denotes |
Abstract |
| T161 |
116-126 |
Sentence |
denotes |
Background |
| T3 |
116-126 |
Sentence |
denotes |
Background |
| T162 |
127-272 |
Sentence |
denotes |
Bone morphogenetic proteins (BMPs) belong to the TGF-β superfamily and are secreted proteins with pleiotropic roles in many different cell types. |
| T4 |
127-272 |
Sentence |
denotes |
Bone morphogenetic proteins (BMPs) belong to the TGF-β superfamily and are secreted proteins with pleiotropic roles in many different cell types. |
| T163 |
273-393 |
Sentence |
denotes |
A potential role of BMP-6 in the immune system has been implied by various studies of malignant and rheumatoid diseases. |
| T5 |
273-393 |
Sentence |
denotes |
A potential role of BMP-6 in the immune system has been implied by various studies of malignant and rheumatoid diseases. |
| T164 |
394-487 |
Sentence |
denotes |
In the present study, we explored the role of BMP-6 in normal human peripheral blood B cells. |
| T6 |
394-487 |
Sentence |
denotes |
In the present study, we explored the role of BMP-6 in normal human peripheral blood B cells. |
| T165 |
489-496 |
Sentence |
denotes |
Results |
| T7 |
489-496 |
Sentence |
denotes |
Results |
| T166 |
497-619 |
Sentence |
denotes |
The B cells were found to express BMP type I and type II receptors and BMP-6 rapidly induced phosphorylation of Smad1/5/8. |
| T8 |
497-619 |
Sentence |
denotes |
The B cells were found to express BMP type I and type II receptors and BMP-6 rapidly induced phosphorylation of Smad1/5/8. |
| T167 |
620-760 |
Sentence |
denotes |
Furthermore, Smad-phosphorylation was followed by upregulation of Id1 mRNA and Id1 protein, whereas Id2 and Id3 expression was not affected. |
| T9 |
620-760 |
Sentence |
denotes |
Furthermore, Smad-phosphorylation was followed by upregulation of Id1 mRNA and Id1 protein, whereas Id2 and Id3 expression was not affected. |
| T168 |
761-961 |
Sentence |
denotes |
Furthermore, we found that BMP-6 had an antiproliferative effect both in naïve (CD19+CD27-) and memory B cells (CD19+CD27+) stimulated with anti-IgM alone or the combined action of anti-IgM and CD40L. |
| T10 |
761-961 |
Sentence |
denotes |
Furthermore, we found that BMP-6 had an antiproliferative effect both in naïve (CD19+CD27-) and memory B cells (CD19+CD27+) stimulated with anti-IgM alone or the combined action of anti-IgM and CD40L. |
| T169 |
962-1029 |
Sentence |
denotes |
Additionally, BMP-6 induced cell death in activated memory B cells. |
| T11 |
962-1029 |
Sentence |
denotes |
Additionally, BMP-6 induced cell death in activated memory B cells. |
| T170 |
1030-1153 |
Sentence |
denotes |
Importantly, the antiproliferative effect of BMP-6 in B-cells was completely neutralized by the natural antagonist, noggin. |
| T12 |
1030-1153 |
Sentence |
denotes |
Importantly, the antiproliferative effect of BMP-6 in B-cells was completely neutralized by the natural antagonist, noggin. |
| T171 |
1154-1249 |
Sentence |
denotes |
Furthermore, B cells were demonstrated to upregulate BMP-6 mRNA upon stimulation with anti-IgM. |
| T13 |
1154-1249 |
Sentence |
denotes |
Furthermore, B cells were demonstrated to upregulate BMP-6 mRNA upon stimulation with anti-IgM. |
| T172 |
1251-1261 |
Sentence |
denotes |
Conclusion |
| T14 |
1251-1261 |
Sentence |
denotes |
Conclusion |
| T173 |
1262-1400 |
Sentence |
denotes |
In mature human B cells, BMP-6 inhibited cell growth, and rapidly induced phosphorylation of Smad1/5/8 followed by an upregulation of Id1. |
| T15 |
1262-1400 |
Sentence |
denotes |
In mature human B cells, BMP-6 inhibited cell growth, and rapidly induced phosphorylation of Smad1/5/8 followed by an upregulation of Id1. |
| T16 |
1403-1413 |
Sentence |
denotes |
Background |
| T1034 |
1414-1581 |
Sentence |
denotes |
Members of the transforming growth factor β (TGF-β) superfamily play central roles in controlling cellular proliferation, differentiation, migration and apoptosis [1]. |
| T17 |
1414-1581 |
Sentence |
denotes |
Members of the transforming growth factor β (TGF-β) superfamily play central roles in controlling cellular proliferation, differentiation, migration and apoptosis [1]. |
| T1035 |
1582-1759 |
Sentence |
denotes |
These cytokines can be divided into three subgroups: TGF-β, the activins/inhibins, and the bone morphogenetic proteins (BMPs), of which the latter constitute the largest family. |
| T18 |
1582-1759 |
Sentence |
denotes |
These cytokines can be divided into three subgroups: TGF-β, the activins/inhibins, and the bone morphogenetic proteins (BMPs), of which the latter constitute the largest family. |
| T1036 |
1760-1903 |
Sentence |
denotes |
BMPs are 30–38 kDa hetero- or homodimeric proteins originally identified by their ability to induce ectopic cartilage and bone formation [2,3]. |
| T19 |
1760-1903 |
Sentence |
denotes |
BMPs are 30–38 kDa hetero- or homodimeric proteins originally identified by their ability to induce ectopic cartilage and bone formation [2,3]. |
| T1037 |
1904-2041 |
Sentence |
denotes |
Several studies have demonstrated an essential role of these proteins during embryogenesis, and more recently, also in adult tissues [1]. |
| T20 |
1904-2041 |
Sentence |
denotes |
Several studies have demonstrated an essential role of these proteins during embryogenesis, and more recently, also in adult tissues [1]. |
| T1038 |
2042-2202 |
Sentence |
denotes |
TGF-β has been intensively studied in normal and malignant haematopoietic cells and is one of the most potent endogenous negative regulators known to date. [4]. |
| T21 |
2042-2202 |
Sentence |
denotes |
TGF-β has been intensively studied in normal and malignant haematopoietic cells and is one of the most potent endogenous negative regulators known to date. [4]. |
| T1039 |
2203-2289 |
Sentence |
denotes |
In contrast, the effect of BMPs in the immune system has not been widely investigated. |
| T22 |
2203-2289 |
Sentence |
denotes |
In contrast, the effect of BMPs in the immune system has not been widely investigated. |
| T1040 |
2290-2435 |
Sentence |
denotes |
In that respect, BMP- 2, -4 and -7 have been found to control differentiation of hematopoietic stem cells [5] and early T cell development [6,7]. |
| T23 |
2290-2435 |
Sentence |
denotes |
In that respect, BMP- 2, -4 and -7 have been found to control differentiation of hematopoietic stem cells [5] and early T cell development [6,7]. |
| T1041 |
2436-2556 |
Sentence |
denotes |
BMP-6 has been reported to reduce the number of cobblestone-area-forming cells of normal human haematopoietic cells [8]. |
| T24 |
2436-2556 |
Sentence |
denotes |
BMP-6 has been reported to reduce the number of cobblestone-area-forming cells of normal human haematopoietic cells [8]. |
| T1042 |
2557-2674 |
Sentence |
denotes |
Furthermore, BMP-2, -4, 6 and -7 had an antiproliferative and a proapoptotic effect on multiple myeloma cells [9-11]. |
| T25 |
2557-2674 |
Sentence |
denotes |
Furthermore, BMP-2, -4, 6 and -7 had an antiproliferative and a proapoptotic effect on multiple myeloma cells [9-11]. |
| T1043 |
2675-2887 |
Sentence |
denotes |
In addition, by gene expression profiling, BMP-6 significantly increased the predictive value for a multi-gene signature test and was associated with a poor outcome in diffuse large B cell lymphomas (DLBCL) [12]. |
| T26 |
2675-2887 |
Sentence |
denotes |
In addition, by gene expression profiling, BMP-6 significantly increased the predictive value for a multi-gene signature test and was associated with a poor outcome in diffuse large B cell lymphomas (DLBCL) [12]. |
| T1044 |
2888-3144 |
Sentence |
denotes |
BMP-6, like the other BMP members, signals through ligation and heterodimerzation of BMP type I [activin-like-kinase (ALK)] and type II serine-threonine kinase receptors, which subsequently propagates the signal downstream by phosphorylating Smad proteins. |
| T27 |
2888-3144 |
Sentence |
denotes |
BMP-6, like the other BMP members, signals through ligation and heterodimerzation of BMP type I [activin-like-kinase (ALK)] and type II serine-threonine kinase receptors, which subsequently propagates the signal downstream by phosphorylating Smad proteins. |
| T1045 |
3145-3380 |
Sentence |
denotes |
BMP-6 can signal through the ligation of the type I receptors Act-RIA, BMP-RIA, and BMP-RIB and the type II receptors BMP-RII, Act-RIIA and Act-RIIB, which lead to the phosphorylation of the receptor Smads (Smad-1, Smad-5, and Smad-8). |
| T28 |
3145-3380 |
Sentence |
denotes |
BMP-6 can signal through the ligation of the type I receptors Act-RIA, BMP-RIA, and BMP-RIB and the type II receptors BMP-RII, Act-RIIA and Act-RIIB, which lead to the phosphorylation of the receptor Smads (Smad-1, Smad-5, and Smad-8). |
| T1046 |
3381-3517 |
Sentence |
denotes |
The R- Smads then form complexes with the co-Smad (Smad4) and are translocated into the nucleus where they exert gene regulation [1,13]. |
| T29 |
3381-3517 |
Sentence |
denotes |
The R- Smads then form complexes with the co-Smad (Smad4) and are translocated into the nucleus where they exert gene regulation [1,13]. |
| T1047 |
3518-3675 |
Sentence |
denotes |
Given the reported role of BMP-6 in B-cell malignancies and haematopoietic progenitor cells, we wanted to explore its potential role in normal human B cells. |
| T30 |
3518-3675 |
Sentence |
denotes |
Given the reported role of BMP-6 in B-cell malignancies and haematopoietic progenitor cells, we wanted to explore its potential role in normal human B cells. |
| T1048 |
3676-3773 |
Sentence |
denotes |
We studied the effects of BMP-6 on proliferation and apoptosis on resting and stimulated B cells. |
| T31 |
3676-3773 |
Sentence |
denotes |
We studied the effects of BMP-6 on proliferation and apoptosis on resting and stimulated B cells. |
| T1049 |
3774-3949 |
Sentence |
denotes |
Furthermore, the expression of BMP receptors and BMP-6 induced activation of the Smad signalling pathway with subsequent regulation of the target genes Id1–Id4, were resolved. |
| T32 |
3774-3949 |
Sentence |
denotes |
Furthermore, the expression of BMP receptors and BMP-6 induced activation of the Smad signalling pathway with subsequent regulation of the target genes Id1–Id4, were resolved. |
| T1050 |
3950-4028 |
Sentence |
denotes |
Finally, we investigated whether B cells also were capable of producing BMP-6. |
| T33 |
3950-4028 |
Sentence |
denotes |
Finally, we investigated whether B cells also were capable of producing BMP-6. |
| T34 |
4030-4037 |
Sentence |
denotes |
Results |
| T2626 |
4039-4101 |
Sentence |
denotes |
BMP-6 inhibits anti-IgM induced proliferation of human B cells |
| T35 |
4039-4101 |
Sentence |
denotes |
BMP-6 inhibits anti-IgM induced proliferation of human B cells |
| T2627 |
4102-4240 |
Sentence |
denotes |
The effects of BMP-6 on normal and neoplastic hematopoietic cells prompted us to investigate the effects of BMP-6 on normal human B cells. |
| T36 |
4102-4240 |
Sentence |
denotes |
The effects of BMP-6 on normal and neoplastic hematopoietic cells prompted us to investigate the effects of BMP-6 on normal human B cells. |
| T2628 |
4241-4392 |
Sentence |
denotes |
All experiments in this study were performed under serum-free conditions as FCS has been shown to interfere with BMP-signalling [14](own observations). |
| T37 |
4241-4392 |
Sentence |
denotes |
All experiments in this study were performed under serum-free conditions as FCS has been shown to interfere with BMP-signalling [14](own observations). |
| T2629 |
4393-4566 |
Sentence |
denotes |
To study the effect of BMP-6 on proliferation, B-cells from healthy volunteers were stimulated with anti-IgM and/or CD40L in the presence or absence of BMP-6 for three days. |
| T38 |
4393-4566 |
Sentence |
denotes |
To study the effect of BMP-6 on proliferation, B-cells from healthy volunteers were stimulated with anti-IgM and/or CD40L in the presence or absence of BMP-6 for three days. |
| T2630 |
4567-4681 |
Sentence |
denotes |
We found that BMP-6 led to a 35% mean reduction of anti-IgM- induced DNA synthesis (n = 8; p ≤ 0.0002, Figure 1A). |
| T39 |
4567-4681 |
Sentence |
denotes |
We found that BMP-6 led to a 35% mean reduction of anti-IgM- induced DNA synthesis (n = 8; p ≤ 0.0002, Figure 1A). |
| T2631 |
4682-4795 |
Sentence |
denotes |
Similar results were obtained for B cells treated with anti-IgM and CD40L (26% mean reduction, n = 6; p ≤ 0.023). |
| T40 |
4682-4795 |
Sentence |
denotes |
Similar results were obtained for B cells treated with anti-IgM and CD40L (26% mean reduction, n = 6; p ≤ 0.023). |
| T2632 |
4796-4985 |
Sentence |
denotes |
The BMP-6-induced inhibition of proliferation was dose-dependent in both peripheral B cells (Figure 1B) and the Burkitt lymphoma cell line Ramos (40% reduction of DNA synthesis, Figure 1C). |
| T41 |
4796-4985 |
Sentence |
denotes |
The BMP-6-induced inhibition of proliferation was dose-dependent in both peripheral B cells (Figure 1B) and the Burkitt lymphoma cell line Ramos (40% reduction of DNA synthesis, Figure 1C). |
| T2633 |
4986-5084 |
Sentence |
denotes |
The BMP-6 effects could be reversed by addition of the extracellular inhibitor Noggin (Figure 1D). |
| T42 |
4986-5084 |
Sentence |
denotes |
The BMP-6 effects could be reversed by addition of the extracellular inhibitor Noggin (Figure 1D). |
| T2634 |
5085-5220 |
Sentence |
denotes |
Similarly, a combination of the soluble BMP receptors BMP-RIB-Fc and BMP-RII-Fc also neutralized the effects of BMP-6 (data not shown). |
| T43 |
5085-5220 |
Sentence |
denotes |
Similarly, a combination of the soluble BMP receptors BMP-RIB-Fc and BMP-RII-Fc also neutralized the effects of BMP-6 (data not shown). |
| T2635 |
5221-5308 |
Sentence |
denotes |
Next, we wanted to test whether BMP-6 had different effect on naïve and memory B cells. |
| T44 |
5221-5308 |
Sentence |
denotes |
Next, we wanted to test whether BMP-6 had different effect on naïve and memory B cells. |
| T2636 |
5309-5525 |
Sentence |
denotes |
Naïve (CD19+CD27-) and memory (CD19+CD27+) B cells were isolated from peripheral blood by cell sorting of immunobead-isolated CD19+ B cells [15], and tested for their capacity to proliferate in the presence of BMP-6. |
| T45 |
5309-5525 |
Sentence |
denotes |
Naïve (CD19+CD27-) and memory (CD19+CD27+) B cells were isolated from peripheral blood by cell sorting of immunobead-isolated CD19+ B cells [15], and tested for their capacity to proliferate in the presence of BMP-6. |
| T2637 |
5526-5770 |
Sentence |
denotes |
However, BMP-6 inhibited anti-IgM induced DNA synthesis in the two subpopulations to a similar extent, with a mean reduction of DNA-synthesis of 45% (n = 5; p ≤ 0,004) for naïve B cells and 48% (n = 5; p ≤ 0,001) for memory B cells (Figure 1E). |
| T46 |
5526-5770 |
Sentence |
denotes |
However, BMP-6 inhibited anti-IgM induced DNA synthesis in the two subpopulations to a similar extent, with a mean reduction of DNA-synthesis of 45% (n = 5; p ≤ 0,004) for naïve B cells and 48% (n = 5; p ≤ 0,001) for memory B cells (Figure 1E). |
| T3578 |
5772-5836 |
Sentence |
denotes |
BMP-6 induces cell death in human memory B cells and Ramos cells |
| T47 |
5772-5836 |
Sentence |
denotes |
BMP-6 induces cell death in human memory B cells and Ramos cells |
| T3579 |
5837-5930 |
Sentence |
denotes |
Next, we wanted to establish whether BMP-6 also could affect the viability of normal B cells. |
| T48 |
5837-5930 |
Sentence |
denotes |
Next, we wanted to establish whether BMP-6 also could affect the viability of normal B cells. |
| T3580 |
5931-6044 |
Sentence |
denotes |
Cell viability was determined by propidium iodide (PI) staining after culture with or without BMP-6 for 48 hours. |
| T49 |
5931-6044 |
Sentence |
denotes |
Cell viability was determined by propidium iodide (PI) staining after culture with or without BMP-6 for 48 hours. |
| T3581 |
6045-6205 |
Sentence |
denotes |
Interestingly, BMP-6 showed a small, but reproducible mean increase of cell death from 17 to 23% (n = 5; p ≤ 0,003) in anti-IgM stimulated CD27+ memory B cells. |
| T50 |
6045-6205 |
Sentence |
denotes |
Interestingly, BMP-6 showed a small, but reproducible mean increase of cell death from 17 to 23% (n = 5; p ≤ 0,003) in anti-IgM stimulated CD27+ memory B cells. |
| T3582 |
6206-6334 |
Sentence |
denotes |
Furthermore, Ramos cells showed a mean increase in cell death from 20 to 50% (n = 3, p < 0,001, figure 3) after BMP-6 treatment. |
| T51 |
6206-6334 |
Sentence |
denotes |
Furthermore, Ramos cells showed a mean increase in cell death from 20 to 50% (n = 3, p < 0,001, figure 3) after BMP-6 treatment. |
| T3583 |
6335-6500 |
Sentence |
denotes |
In contrast, cell death of total CD19+ cells (n = 6; p ≤ 0,32; data not shown) or CD27-IgG- naïve B cells was not significantly affected (n = 5; p ≤ 0,65, figure 2). |
| T52 |
6335-6500 |
Sentence |
denotes |
In contrast, cell death of total CD19+ cells (n = 6; p ≤ 0,32; data not shown) or CD27-IgG- naïve B cells was not significantly affected (n = 5; p ≤ 0,65, figure 2). |
| T4052 |
6502-6539 |
Sentence |
denotes |
Human B cells express BMP-6 receptors |
| T53 |
6502-6539 |
Sentence |
denotes |
Human B cells express BMP-6 receptors |
| T4053 |
6540-6645 |
Sentence |
denotes |
Detailed knowledge regarding expression of different BMP receptors in B cells is currently not available. |
| T54 |
6540-6645 |
Sentence |
denotes |
Detailed knowledge regarding expression of different BMP receptors in B cells is currently not available. |
| T4054 |
6646-6774 |
Sentence |
denotes |
To further elucidate the role of BMPs in human B cells, we performed western blot analysis for type I and type II BMP receptors. |
| T55 |
6646-6774 |
Sentence |
denotes |
To further elucidate the role of BMPs in human B cells, we performed western blot analysis for type I and type II BMP receptors. |
| T4055 |
6775-6938 |
Sentence |
denotes |
This analysis revealed that the type I receptors Act-RIA, BMP-RIB and the type II receptors BMP-RII and Act-RIIb are expressed on resting human B-cells (Figure 4). |
| T56 |
6775-6938 |
Sentence |
denotes |
This analysis revealed that the type I receptors Act-RIA, BMP-RIB and the type II receptors BMP-RII and Act-RIIb are expressed on resting human B-cells (Figure 4). |
| T4056 |
6939-7087 |
Sentence |
denotes |
Ramos cells expressed the type I receptors Act-RIA, weakly BMP-RIB and the type II receptor BMP-RII, but more weakly than normal B cells (Figure 4). |
| T57 |
6939-7087 |
Sentence |
denotes |
Ramos cells expressed the type I receptors Act-RIA, weakly BMP-RIB and the type II receptor BMP-RII, but more weakly than normal B cells (Figure 4). |
| T4057 |
7088-7165 |
Sentence |
denotes |
HL60 cells were used for comparison and weakly expressed Act-RIA and BMP-RII. |
| T58 |
7088-7165 |
Sentence |
denotes |
HL60 cells were used for comparison and weakly expressed Act-RIA and BMP-RII. |
| T4058 |
7166-7308 |
Sentence |
denotes |
Taken together, these data show that normal human B cells and Ramos cells express a set of BMP receptors, previously shown to bind BMP-6 [16]. |
| T59 |
7166-7308 |
Sentence |
denotes |
Taken together, these data show that normal human B cells and Ramos cells express a set of BMP receptors, previously shown to bind BMP-6 [16]. |
| T4599 |
7310-7352 |
Sentence |
denotes |
BMP-6 induces phosphorylation of Smad1/5/8 |
| T60 |
7310-7352 |
Sentence |
denotes |
BMP-6 induces phosphorylation of Smad1/5/8 |
| T4600 |
7353-7449 |
Sentence |
denotes |
Upon ligand binding, the type II receptor transphosphorylates and activates the type I receptor. |
| T61 |
7353-7449 |
Sentence |
denotes |
Upon ligand binding, the type II receptor transphosphorylates and activates the type I receptor. |
| T4601 |
7450-7499 |
Sentence |
denotes |
Type I receptors can signal via several pathways. |
| T62 |
7450-7499 |
Sentence |
denotes |
Type I receptors can signal via several pathways. |
| T4602 |
7500-7644 |
Sentence |
denotes |
We examined the effect of BMP-6 on Smad phosphorylation, as the activation of Smad is considered to be a major signalling pathway for BMPs [17]. |
| T63 |
7500-7644 |
Sentence |
denotes |
We examined the effect of BMP-6 on Smad phosphorylation, as the activation of Smad is considered to be a major signalling pathway for BMPs [17]. |
| T4603 |
7645-7750 |
Sentence |
denotes |
B cells were cultured in serum-free media over night and then treated with BMP-6 for various time points. |
| T64 |
7645-7750 |
Sentence |
denotes |
B cells were cultured in serum-free media over night and then treated with BMP-6 for various time points. |
| T4604 |
7751-7886 |
Sentence |
denotes |
Total protein lysates were prepared, and the amounts of the phosphorylated forms of Smad1/5/8 were determined by western blot analysis. |
| T65 |
7751-7886 |
Sentence |
denotes |
Total protein lysates were prepared, and the amounts of the phosphorylated forms of Smad1/5/8 were determined by western blot analysis. |
| T66 |
7887-7965 |
Sentence |
denotes |
Interestingly, treatment with 500 ng/ml BMP-6 induced phosphorylation of Smad. |
| T4605 |
7887-8108 |
Sentence |
denotes |
Interestingly, treatment with 500 ng/ml BMP-6 induced phosphorylation of Smad. The BMP-6 induced phosphorylation was high at the earliest time point tested (15 minutes), and remained high for at least 48 hours (Figure 5). |
| T67 |
7966-8108 |
Sentence |
denotes |
The BMP-6 induced phosphorylation was high at the earliest time point tested (15 minutes), and remained high for at least 48 hours (Figure 5). |
| T4606 |
8109-8197 |
Sentence |
denotes |
A similar phosphorylation was observed in Ramos cells, but not in HL60 cells (Figure 6). |
| T68 |
8109-8197 |
Sentence |
denotes |
A similar phosphorylation was observed in Ramos cells, but not in HL60 cells (Figure 6). |
| T4607 |
8198-8331 |
Sentence |
denotes |
Furthermore, we also tested whether other known downstream signalling pathways of BMP-6 could be triggered by BMP-6 in human B cells. |
| T69 |
8198-8331 |
Sentence |
denotes |
Furthermore, we also tested whether other known downstream signalling pathways of BMP-6 could be triggered by BMP-6 in human B cells. |
| T4608 |
8332-8478 |
Sentence |
denotes |
However, we did not observe any significant changes in the level of phospho-STAT3 or phospho-p38 upon BMP-6 treatment of B cells (data not shown). |
| T70 |
8332-8478 |
Sentence |
denotes |
However, we did not observe any significant changes in the level of phospho-STAT3 or phospho-p38 upon BMP-6 treatment of B cells (data not shown). |
| T5443 |
8480-8513 |
Sentence |
denotes |
BMP-6 induces upregulation of Id1 |
| T71 |
8480-8513 |
Sentence |
denotes |
BMP-6 induces upregulation of Id1 |
| T5444 |
8514-8655 |
Sentence |
denotes |
Next, we wanted to explore whether the BMP-6 induced phosphorylation of Smad 1/5/8 also could induce transcriptional changes of target genes. |
| T72 |
8514-8655 |
Sentence |
denotes |
Next, we wanted to explore whether the BMP-6 induced phosphorylation of Smad 1/5/8 also could induce transcriptional changes of target genes. |
| T5445 |
8656-8794 |
Sentence |
denotes |
In this regard, the inhibitors of DNA binding proteins (Ids) are considered to be some of the major target genes for Smad-signalling [17]. |
| T73 |
8656-8794 |
Sentence |
denotes |
In this regard, the inhibitors of DNA binding proteins (Ids) are considered to be some of the major target genes for Smad-signalling [17]. |
| T5446 |
8795-8971 |
Sentence |
denotes |
Thus, B cells were pre-incubated over night in X-VIVO 15, and then cultured in medium alone or in the presence of BMP-6 for various time points before preparation of total RNA. |
| T74 |
8795-8971 |
Sentence |
denotes |
Thus, B cells were pre-incubated over night in X-VIVO 15, and then cultured in medium alone or in the presence of BMP-6 for various time points before preparation of total RNA. |
| T5447 |
8972-9034 |
Sentence |
denotes |
The amount of Id1–Id4 mRNA was quantified by real-time RT-PCR. |
| T75 |
8972-9034 |
Sentence |
denotes |
The amount of Id1–Id4 mRNA was quantified by real-time RT-PCR. |
| T5448 |
9035-9144 |
Sentence |
denotes |
Interestingly, we observed a specific four-fold upregulation of Id1 mRNA in BMP-6-treated B cells (Figure 7). |
| T76 |
9035-9144 |
Sentence |
denotes |
Interestingly, we observed a specific four-fold upregulation of Id1 mRNA in BMP-6-treated B cells (Figure 7). |
| T5449 |
9145-9326 |
Sentence |
denotes |
The up-regulation of Id1 mRNA was characteristic of an early inducible gene, with maximal upregulation two hours after the addition of BMP-6 and returned to baseline after 24 hours. |
| T77 |
9145-9326 |
Sentence |
denotes |
The up-regulation of Id1 mRNA was characteristic of an early inducible gene, with maximal upregulation two hours after the addition of BMP-6 and returned to baseline after 24 hours. |
| T5450 |
9327-9470 |
Sentence |
denotes |
In contrast, no significant changes were observed for Id2 and Id3 mRNA, whereas Id4-transcripts were not detectable (Figure 7, data not shown). |
| T78 |
9327-9470 |
Sentence |
denotes |
In contrast, no significant changes were observed for Id2 and Id3 mRNA, whereas Id4-transcripts were not detectable (Figure 7, data not shown). |
| T5451 |
9471-9611 |
Sentence |
denotes |
Western blot analysis revealed that the BMP-6-induced upregulation of Id1 mRNA also was correlated with upregulation of Id1 protein as well. |
| T79 |
9471-9611 |
Sentence |
denotes |
Western blot analysis revealed that the BMP-6-induced upregulation of Id1 mRNA also was correlated with upregulation of Id1 protein as well. |
| T5452 |
9612-9811 |
Sentence |
denotes |
The increase in Id1 protein level was detectable after one hour and increased until 24 hours after BMP-6 addition, showing a 16-fold upregulation compared with t0 (p ≤ 0.020, n = 4) (Figure 8 and 9). |
| T80 |
9612-9811 |
Sentence |
denotes |
The increase in Id1 protein level was detectable after one hour and increased until 24 hours after BMP-6 addition, showing a 16-fold upregulation compared with t0 (p ≤ 0.020, n = 4) (Figure 8 and 9). |
| T5453 |
9812-9934 |
Sentence |
denotes |
In line with the mRNA data, no consistent change in the amounts of Id2 and Id3 protein could be observed (Figure 8 and 9). |
| T81 |
9812-9934 |
Sentence |
denotes |
In line with the mRNA data, no consistent change in the amounts of Id2 and Id3 protein could be observed (Figure 8 and 9). |
| T5454 |
9935-10020 |
Sentence |
denotes |
We were able to block the Id1 specific band with a blocking peptide (data not shown). |
| T82 |
9935-10020 |
Sentence |
denotes |
We were able to block the Id1 specific band with a blocking peptide (data not shown). |
| T5455 |
10021-10194 |
Sentence |
denotes |
Taken together, these data suggest that Id1 could be a possible target gene for mediating the effects of BMP-6 in human B cells, whereas Id2 and Id3 not seem to be involved. |
| T83 |
10021-10194 |
Sentence |
denotes |
Taken together, these data suggest that Id1 could be a possible target gene for mediating the effects of BMP-6 in human B cells, whereas Id2 and Id3 not seem to be involved. |
| T6481 |
10196-10223 |
Sentence |
denotes |
BMP-6 production in B cells |
| T84 |
10196-10223 |
Sentence |
denotes |
BMP-6 production in B cells |
| T6482 |
10224-10428 |
Sentence |
denotes |
The fact that BMP-6 has been reported to act as an autocrine stimulator in chondrocytes [18] and ovarium [19], prompted us to investigate whether normal human B cells could produce BMP-6 upon stimulation. |
| T85 |
10224-10428 |
Sentence |
denotes |
The fact that BMP-6 has been reported to act as an autocrine stimulator in chondrocytes [18] and ovarium [19], prompted us to investigate whether normal human B cells could produce BMP-6 upon stimulation. |
| T6483 |
10429-10592 |
Sentence |
denotes |
Ramos cells, which have been described to express BMP-6 mRNA endogenously [20], and the T cell line Jurkat, served as positive and negative controls, respectively. |
| T86 |
10429-10592 |
Sentence |
denotes |
Ramos cells, which have been described to express BMP-6 mRNA endogenously [20], and the T cell line Jurkat, served as positive and negative controls, respectively. |
| T6484 |
10593-10734 |
Sentence |
denotes |
Endogenous BMP-6 mRNA levels in normal B cells were quantified by real-time RT-PCR after stimulation with anti-IgM for different time points. |
| T87 |
10593-10734 |
Sentence |
denotes |
Endogenous BMP-6 mRNA levels in normal B cells were quantified by real-time RT-PCR after stimulation with anti-IgM for different time points. |
| T6485 |
10735-10912 |
Sentence |
denotes |
Interestingly, the up-regulation of BMP-6 mRNA was characteristic of an early-to intermediate inducible gene with maximal upregulation four hours after the addition of anti-IgM. |
| T88 |
10735-10912 |
Sentence |
denotes |
Interestingly, the up-regulation of BMP-6 mRNA was characteristic of an early-to intermediate inducible gene with maximal upregulation four hours after the addition of anti-IgM. |
| T6486 |
10913-11002 |
Sentence |
denotes |
The level of BMP-6 mRNA was back to baseline after 24 hours upon stimulation (Figure 10). |
| T89 |
10913-11002 |
Sentence |
denotes |
The level of BMP-6 mRNA was back to baseline after 24 hours upon stimulation (Figure 10). |
| T6487 |
11003-11103 |
Sentence |
denotes |
Furthermore, both FCS and human AB-serum induced significant upregulation of BMP-6 mRNA (Figure 11). |
| T90 |
11003-11103 |
Sentence |
denotes |
Furthermore, both FCS and human AB-serum induced significant upregulation of BMP-6 mRNA (Figure 11). |
| T6488 |
11104-11267 |
Sentence |
denotes |
Interestingly, in a separate study we have found that normal human T cells do not express BMP-6 mRNA after activation (Sivertsen et al, manuscript in preparation). |
| T91 |
11104-11267 |
Sentence |
denotes |
Interestingly, in a separate study we have found that normal human T cells do not express BMP-6 mRNA after activation (Sivertsen et al, manuscript in preparation). |
| T6489 |
11268-11379 |
Sentence |
denotes |
Next, we wanted to detect BMP-6 protein in normal B-cells and tested various commercially available antibodies. |
| T92 |
11268-11379 |
Sentence |
denotes |
Next, we wanted to detect BMP-6 protein in normal B-cells and tested various commercially available antibodies. |
| T6490 |
11380-11506 |
Sentence |
denotes |
However, in our hands these anti-BMP-6 antibodies did only recognize the recombinant BMP-6 protein and not the native protein. |
| T93 |
11380-11506 |
Sentence |
denotes |
However, in our hands these anti-BMP-6 antibodies did only recognize the recombinant BMP-6 protein and not the native protein. |
| T94 |
11508-11518 |
Sentence |
denotes |
Discussion |
| T7807 |
11519-11762 |
Sentence |
denotes |
Recent studies have demonstrated an important role for BMP superfamily members in hematopoietic stem cells, early thymocytes [6,7] and B-cell malignancies [8,11,12], but a role for BMPs in normal human B cells has previously not been reported. |
| T95 |
11519-11762 |
Sentence |
denotes |
Recent studies have demonstrated an important role for BMP superfamily members in hematopoietic stem cells, early thymocytes [6,7] and B-cell malignancies [8,11,12], but a role for BMPs in normal human B cells has previously not been reported. |
| T7808 |
11763-11876 |
Sentence |
denotes |
The present study demonstrated a significant antiproliferative effect of BMP-6 in peripheral blood CD19+ B cells. |
| T96 |
11763-11876 |
Sentence |
denotes |
The present study demonstrated a significant antiproliferative effect of BMP-6 in peripheral blood CD19+ B cells. |
| T7809 |
11877-11991 |
Sentence |
denotes |
Additionally, BMP-6 induced cell death in CD27+ memory B cells as well as in a Burkitt lymphoma cell line (Ramos). |
| T97 |
11877-11991 |
Sentence |
denotes |
Additionally, BMP-6 induced cell death in CD27+ memory B cells as well as in a Burkitt lymphoma cell line (Ramos). |
| T7810 |
11992-12077 |
Sentence |
denotes |
Importantly, BMP-6 induced a rapid and marked increase in Smad-1/5/8 phosphorylation. |
| T98 |
11992-12077 |
Sentence |
denotes |
Importantly, BMP-6 induced a rapid and marked increase in Smad-1/5/8 phosphorylation. |
| T7811 |
12078-12210 |
Sentence |
denotes |
Furthermore, the BMP-6 induced Smad phosphorylation was followed by a selective upregulation of Id1 mRNA and subsequent Id1 protein. |
| T99 |
12078-12210 |
Sentence |
denotes |
Furthermore, the BMP-6 induced Smad phosphorylation was followed by a selective upregulation of Id1 mRNA and subsequent Id1 protein. |
| T7812 |
12211-12347 |
Sentence |
denotes |
In the present study, the demonstrated antiproliferative effect of BMP-6 in anti-IgM treated B cells was significant and dose-dependent. |
| T100 |
12211-12347 |
Sentence |
denotes |
In the present study, the demonstrated antiproliferative effect of BMP-6 in anti-IgM treated B cells was significant and dose-dependent. |
| T101 |
12348-12474 |
Sentence |
denotes |
Importantly, the anti-proliferative effect of BMP-6 could be completely neutralized by the use of a natural inhibitor, Noggin. |
| T7813 |
12348-12567 |
Sentence |
denotes |
Importantly, the anti-proliferative effect of BMP-6 could be completely neutralized by the use of a natural inhibitor, Noggin. This is in line with others, showing that Noggin can function as a BMP-6 antagonist [21,22]. |
| T102 |
12475-12567 |
Sentence |
denotes |
This is in line with others, showing that Noggin can function as a BMP-6 antagonist [21,22]. |
| T7814 |
12568-12723 |
Sentence |
denotes |
In addition, the combination of soluble BMP-RIB-Fc and BMP-RII-Fc fusion proteins also neutralized the anti-proliferative effect of BMP-6 in human B cells. |
| T103 |
12568-12723 |
Sentence |
denotes |
In addition, the combination of soluble BMP-RIB-Fc and BMP-RII-Fc fusion proteins also neutralized the anti-proliferative effect of BMP-6 in human B cells. |
| T7815 |
12724-12830 |
Sentence |
denotes |
Interestingly, as for other TGF family members, bifunctional effects have also been demonstrated for BMPs. |
| T104 |
12724-12830 |
Sentence |
denotes |
Interestingly, as for other TGF family members, bifunctional effects have also been demonstrated for BMPs. |
| T7816 |
12831-13084 |
Sentence |
denotes |
Whereas several of the BMPs have been shown to promote proliferation in various cell types including condrocytes [23], liver [24] and granulosa cells [25], antiproliferative effects and induction of apoptosis has been reported for B and T lineage cells. |
| T105 |
12831-13084 |
Sentence |
denotes |
Whereas several of the BMPs have been shown to promote proliferation in various cell types including condrocytes [23], liver [24] and granulosa cells [25], antiproliferative effects and induction of apoptosis has been reported for B and T lineage cells. |
| T7817 |
13085-13237 |
Sentence |
denotes |
Similar effects as demonstrated for BMP-6 on human B cells in the present study, were demonstrated for BMP-2, 4, 6 and -7 in human myeloma cells [9-11]. |
| T106 |
13085-13237 |
Sentence |
denotes |
Similar effects as demonstrated for BMP-6 on human B cells in the present study, were demonstrated for BMP-2, 4, 6 and -7 in human myeloma cells [9-11]. |
| T7818 |
13238-13355 |
Sentence |
denotes |
Other members of the BMP-family have also been reported to induce apoptosis, including in mouse B lineage cells [26]. |
| T107 |
13238-13355 |
Sentence |
denotes |
Other members of the BMP-family have also been reported to induce apoptosis, including in mouse B lineage cells [26]. |
| T7819 |
13356-13413 |
Sentence |
denotes |
Additionally, BMP-4 inhibits thymocyte proliferation [6]. |
| T108 |
13356-13413 |
Sentence |
denotes |
Additionally, BMP-4 inhibits thymocyte proliferation [6]. |
| T7820 |
13414-13550 |
Sentence |
denotes |
Taken together, these data suggest that the role of BMPs in the regulation of proliferation and apoptosis is highly cell type dependent. |
| T109 |
13414-13550 |
Sentence |
denotes |
Taken together, these data suggest that the role of BMPs in the regulation of proliferation and apoptosis is highly cell type dependent. |
| T7821 |
13551-13675 |
Sentence |
denotes |
To examine how BMP-6 exerts its functional effects in B cells, we analysed BMP receptor expression by western blot analysis. |
| T110 |
13551-13675 |
Sentence |
denotes |
To examine how BMP-6 exerts its functional effects in B cells, we analysed BMP receptor expression by western blot analysis. |
| T7822 |
13676-13885 |
Sentence |
denotes |
Human peripheral B cells were found to express the BMP type I receptors Act-RIA and BMP-RIB, and the type II-receptors BMP-RII and Act-RIIb, which signal after binding of several BMPs, including BMP-6 [16,13]. |
| T111 |
13676-13885 |
Sentence |
denotes |
Human peripheral B cells were found to express the BMP type I receptors Act-RIA and BMP-RIB, and the type II-receptors BMP-RII and Act-RIIb, which signal after binding of several BMPs, including BMP-6 [16,13]. |
| T7823 |
13886-13974 |
Sentence |
denotes |
To further explore BMP-6 induced signalling, activation of several pathways is possible. |
| T112 |
13886-13974 |
Sentence |
denotes |
To further explore BMP-6 induced signalling, activation of several pathways is possible. |
| T7824 |
13975-14052 |
Sentence |
denotes |
The major signalling pathway known to date, is activation of R-Smads [13,27]. |
| T113 |
13975-14052 |
Sentence |
denotes |
The major signalling pathway known to date, is activation of R-Smads [13,27]. |
| T7825 |
14053-14183 |
Sentence |
denotes |
In that respect, BMPs have been shown to exert antiproliferative effects in B lineage cells via phosphorylation of R-Smad [11,28]. |
| T114 |
14053-14183 |
Sentence |
denotes |
In that respect, BMPs have been shown to exert antiproliferative effects in B lineage cells via phosphorylation of R-Smad [11,28]. |
| T7826 |
14184-14269 |
Sentence |
denotes |
Furthermore, BMP-2 has been shown to induce activation of STAT3 in myeloma cells [9]. |
| T115 |
14184-14269 |
Sentence |
denotes |
Furthermore, BMP-2 has been shown to induce activation of STAT3 in myeloma cells [9]. |
| T7827 |
14270-14340 |
Sentence |
denotes |
However, phosphorylation of R-Smad was not investigated in that study. |
| T116 |
14270-14340 |
Sentence |
denotes |
However, phosphorylation of R-Smad was not investigated in that study. |
| T7828 |
14341-14405 |
Sentence |
denotes |
BMP-2 has also been shown to induce phosphorylation of p38 [29]. |
| T117 |
14341-14405 |
Sentence |
denotes |
BMP-2 has also been shown to induce phosphorylation of p38 [29]. |
| T7829 |
14406-14603 |
Sentence |
denotes |
Thus, phosphorylation of p38, STAT3 and Smad1/5/8 represent important BMP-signalling pathways that mediated the effects of BMPs and even cross-talk between these pathways has been reported [29,30]. |
| T118 |
14406-14603 |
Sentence |
denotes |
Thus, phosphorylation of p38, STAT3 and Smad1/5/8 represent important BMP-signalling pathways that mediated the effects of BMPs and even cross-talk between these pathways has been reported [29,30]. |
| T7830 |
14604-14749 |
Sentence |
denotes |
In the present study, we were not able to detect BMP-6-induced changes in the phosphorylation status of STAT3 or p38 in human peripheral B cells. |
| T119 |
14604-14749 |
Sentence |
denotes |
In the present study, we were not able to detect BMP-6-induced changes in the phosphorylation status of STAT3 or p38 in human peripheral B cells. |
| T7831 |
14750-14820 |
Sentence |
denotes |
Instead, a rapid and marked phosphorylation of Smad1/5/8 was revealed. |
| T120 |
14750-14820 |
Sentence |
denotes |
Instead, a rapid and marked phosphorylation of Smad1/5/8 was revealed. |
| T7832 |
14821-14953 |
Sentence |
denotes |
In a parallel study, we have found that other BMPs also induced phosphorylation of Smad1/5/8 in peripheral B cells (data not shown). |
| T121 |
14821-14953 |
Sentence |
denotes |
In a parallel study, we have found that other BMPs also induced phosphorylation of Smad1/5/8 in peripheral B cells (data not shown). |
| T7833 |
14954-15120 |
Sentence |
denotes |
We are currently pursuing microarray studies to identify the signalling pathways and target genes that are differently regulated by the various BMPs in human B cells. |
| T122 |
14954-15120 |
Sentence |
denotes |
We are currently pursuing microarray studies to identify the signalling pathways and target genes that are differently regulated by the various BMPs in human B cells. |
| T7834 |
15121-15338 |
Sentence |
denotes |
Upregulation of Id1 via Smad1/5/8 phosphorylation is a known mechanism for BMP-6 signalling in other cell systems [31,32] and regulation of Id-proteins is thought to be an important mechanism for Smad-signalling [17]. |
| T123 |
15121-15338 |
Sentence |
denotes |
Upregulation of Id1 via Smad1/5/8 phosphorylation is a known mechanism for BMP-6 signalling in other cell systems [31,32] and regulation of Id-proteins is thought to be an important mechanism for Smad-signalling [17]. |
| T7835 |
15339-15514 |
Sentence |
denotes |
In the present study, real-time RT-PCR experiments revealed a specific four-fold upregulation for Id1 in BMP-6-treated B cells, while the amount of Id2–Id4 remained unchanged. |
| T124 |
15339-15514 |
Sentence |
denotes |
In the present study, real-time RT-PCR experiments revealed a specific four-fold upregulation for Id1 in BMP-6-treated B cells, while the amount of Id2–Id4 remained unchanged. |
| T7836 |
15515-15672 |
Sentence |
denotes |
In agreement with this, western blot analysis demonstrated an upregulation of Id1 protein, while the amount of Id2 and Id3 protein levels remained unchanged. |
| T125 |
15515-15672 |
Sentence |
denotes |
In agreement with this, western blot analysis demonstrated an upregulation of Id1 protein, while the amount of Id2 and Id3 protein levels remained unchanged. |
| T7837 |
15673-15875 |
Sentence |
denotes |
Previously, Id1 has been considered not to be expressed in later developmental stages than pro-B cells [33,34], and its constitutive expression has been reported to impair mouse B cell development [35]. |
| T126 |
15673-15875 |
Sentence |
denotes |
Previously, Id1 has been considered not to be expressed in later developmental stages than pro-B cells [33,34], and its constitutive expression has been reported to impair mouse B cell development [35]. |
| T7838 |
15876-16021 |
Sentence |
denotes |
Therefore, our demonstration of the time-dependent upregulation of Id1 mRNA and protein in mature normal human B cells is of particular interest. |
| T127 |
15876-16021 |
Sentence |
denotes |
Therefore, our demonstration of the time-dependent upregulation of Id1 mRNA and protein in mature normal human B cells is of particular interest. |
| T7839 |
16022-16180 |
Sentence |
denotes |
In that respect, it is noteworthy that TGF-β signalling in early and mature B cells induces both Id2 and Id3 expression [36,37], but not Id1 (data not shown). |
| T128 |
16022-16180 |
Sentence |
denotes |
In that respect, it is noteworthy that TGF-β signalling in early and mature B cells induces both Id2 and Id3 expression [36,37], but not Id1 (data not shown). |
| T7840 |
16181-16289 |
Sentence |
denotes |
Interestingly, these results show that various members of the TGF-β family regulate Id proteins differently. |
| T129 |
16181-16289 |
Sentence |
denotes |
Interestingly, these results show that various members of the TGF-β family regulate Id proteins differently. |
| T7841 |
16290-16379 |
Sentence |
denotes |
Id2 and Id3 are considered to be the Id proteins mainly expressed in mature B cells [38]. |
| T130 |
16290-16379 |
Sentence |
denotes |
Id2 and Id3 are considered to be the Id proteins mainly expressed in mature B cells [38]. |
| T7842 |
16380-16496 |
Sentence |
denotes |
The present study also found Id2 and Id3 protein in B cells to be more highly expressed than Id1 in resting B cells. |
| T131 |
16380-16496 |
Sentence |
denotes |
The present study also found Id2 and Id3 protein in B cells to be more highly expressed than Id1 in resting B cells. |
| T7843 |
16497-16588 |
Sentence |
denotes |
However, BMP-6 did not induce significant changes in the protein expression of Id2 and Id3. |
| T132 |
16497-16588 |
Sentence |
denotes |
However, BMP-6 did not induce significant changes in the protein expression of Id2 and Id3. |
| T7844 |
16589-16699 |
Sentence |
denotes |
It is believed that Id proteins block differentiation and promote proliferation in various cell types [39,33]. |
| T133 |
16589-16699 |
Sentence |
denotes |
It is believed that Id proteins block differentiation and promote proliferation in various cell types [39,33]. |
| T7845 |
16700-16850 |
Sentence |
denotes |
Id proteins act as dominant-negative inhibitors of E-proteins and Pax5 function by forming dimers with these proteins, making them unable to bind DNA. |
| T134 |
16700-16850 |
Sentence |
denotes |
Id proteins act as dominant-negative inhibitors of E-proteins and Pax5 function by forming dimers with these proteins, making them unable to bind DNA. |
| T7846 |
16851-16983 |
Sentence |
denotes |
It has been proposed that the balance among E-proteins, Pax5 and Id proteins might have an important role in activated B cells [38]. |
| T135 |
16851-16983 |
Sentence |
denotes |
It has been proposed that the balance among E-proteins, Pax5 and Id proteins might have an important role in activated B cells [38]. |
| T7847 |
16984-17149 |
Sentence |
denotes |
In that respect, E-proteins have been implicated in both the promotion and inhibition of cell survival and growth at different points in lymphocyte development [40]. |
| T136 |
16984-17149 |
Sentence |
denotes |
In that respect, E-proteins have been implicated in both the promotion and inhibition of cell survival and growth at different points in lymphocyte development [40]. |
| T7848 |
17150-17419 |
Sentence |
denotes |
The antiproliferative and death inducing effect of BMP-6 in B cells with concomitant upregulation of Id1 protein is therefore in line with the view that Id proteins are required for the induction of growth arrest and apoptosis in B-lymphocyte progenitors by TGF-β [40]. |
| T137 |
17150-17419 |
Sentence |
denotes |
The antiproliferative and death inducing effect of BMP-6 in B cells with concomitant upregulation of Id1 protein is therefore in line with the view that Id proteins are required for the induction of growth arrest and apoptosis in B-lymphocyte progenitors by TGF-β [40]. |
| T7849 |
17420-17556 |
Sentence |
denotes |
Furthermore, Id proteins are known as important parts of signalling pathways involved in development, cell cycle and tumorigenesis [32]. |
| T138 |
17420-17556 |
Sentence |
denotes |
Furthermore, Id proteins are known as important parts of signalling pathways involved in development, cell cycle and tumorigenesis [32]. |
| T7850 |
17557-17817 |
Sentence |
denotes |
It is well established that various members of the Id family are overexpressed in a range of human tumours and generally, Id1 appears to be the family member most widely overexpressed in a variety of human malignancies [41], including multiple myeloma [42,32]. |
| T139 |
17557-17817 |
Sentence |
denotes |
It is well established that various members of the Id family are overexpressed in a range of human tumours and generally, Id1 appears to be the family member most widely overexpressed in a variety of human malignancies [41], including multiple myeloma [42,32]. |
| T7851 |
17818-18000 |
Sentence |
denotes |
Additionally, our findings that BMP-6 activates intracellular signalling pathways in human B cells might be of potential pathophysiological significance in lymphoma and inflammation. |
| T140 |
17818-18000 |
Sentence |
denotes |
Additionally, our findings that BMP-6 activates intracellular signalling pathways in human B cells might be of potential pathophysiological significance in lymphoma and inflammation. |
| T7852 |
18001-18094 |
Sentence |
denotes |
High BMP-6 mRNA expression in DLBCL has been shown to correlate to unfavourable outcome [12]. |
| T141 |
18001-18094 |
Sentence |
denotes |
High BMP-6 mRNA expression in DLBCL has been shown to correlate to unfavourable outcome [12]. |
| T7853 |
18095-18291 |
Sentence |
denotes |
In this respect, it is of interest that targeted expression of Id1 to B-lymphocytes resulted in aberrant B cell development, massive apoptosis, and subsequent development of B cell lymphomas [35]. |
| T142 |
18095-18291 |
Sentence |
denotes |
In this respect, it is of interest that targeted expression of Id1 to B-lymphocytes resulted in aberrant B cell development, massive apoptosis, and subsequent development of B cell lymphomas [35]. |
| T7854 |
18292-18465 |
Sentence |
denotes |
Moreover, BMP-6 has been suggested to play a role in rheumatoid arthritis (RA) [43,44] and elevated levels of Id1 and Id3 have been found in the synovia of RA-patients [45]. |
| T143 |
18292-18465 |
Sentence |
denotes |
Moreover, BMP-6 has been suggested to play a role in rheumatoid arthritis (RA) [43,44] and elevated levels of Id1 and Id3 have been found in the synovia of RA-patients [45]. |
| T7855 |
18466-18626 |
Sentence |
denotes |
Altogether, these results point to an important role for Id proteins in the regulation of normal B cell homeostasis and in diseases, where B cells are involved. |
| T144 |
18466-18626 |
Sentence |
denotes |
Altogether, these results point to an important role for Id proteins in the regulation of normal B cell homeostasis and in diseases, where B cells are involved. |
| T7856 |
18627-18780 |
Sentence |
denotes |
It will therefore be important to further elucidate the role of Id-1 in human B cells by selective over expression or inhibition of Id-1 gene expression. |
| T145 |
18627-18780 |
Sentence |
denotes |
It will therefore be important to further elucidate the role of Id-1 in human B cells by selective over expression or inhibition of Id-1 gene expression. |
| T7857 |
18781-19021 |
Sentence |
denotes |
Given the role of BMP-6 in mature human B cells demonstrated here, identification of BMP-6 producing cells in vivo with possibility of interaction with naïve and memory B cells might contribute to the understanding of mature B cell biology. |
| T146 |
18781-19021 |
Sentence |
denotes |
Given the role of BMP-6 in mature human B cells demonstrated here, identification of BMP-6 producing cells in vivo with possibility of interaction with naïve and memory B cells might contribute to the understanding of mature B cell biology. |
| T7858 |
19022-19110 |
Sentence |
denotes |
High BMP-6 mRNA expression in DLBCL has been detected by gene expression profiling [12]. |
| T147 |
19022-19110 |
Sentence |
denotes |
High BMP-6 mRNA expression in DLBCL has been detected by gene expression profiling [12]. |
| T7859 |
19111-19215 |
Sentence |
denotes |
Furthermore, production of BMP-6 transcripts in normal activated B cells was detected in the same study. |
| T148 |
19111-19215 |
Sentence |
denotes |
Furthermore, production of BMP-6 transcripts in normal activated B cells was detected in the same study. |
| T7860 |
19216-19323 |
Sentence |
denotes |
Of note, an autocrine BMP-6 loop has been reported by others in chondrocytes and in the ovarium [46,19,18]. |
| T149 |
19216-19323 |
Sentence |
denotes |
Of note, an autocrine BMP-6 loop has been reported by others in chondrocytes and in the ovarium [46,19,18]. |
| T7861 |
19324-19417 |
Sentence |
denotes |
Therefore, we wanted to explore the possibility for an autocrine BMP-6 loop in human B cells. |
| T150 |
19324-19417 |
Sentence |
denotes |
Therefore, we wanted to explore the possibility for an autocrine BMP-6 loop in human B cells. |
| T7862 |
19418-19642 |
Sentence |
denotes |
We analysed the expression BMP-6 mRNA in peripheral blood B cells by real-time PCR, and report here the upregulation of endogenous BMP-6 transcripts after stimulation with FCS, human AB-serum and, most importantly, anti-IgM. |
| T151 |
19418-19642 |
Sentence |
denotes |
We analysed the expression BMP-6 mRNA in peripheral blood B cells by real-time PCR, and report here the upregulation of endogenous BMP-6 transcripts after stimulation with FCS, human AB-serum and, most importantly, anti-IgM. |
| T7863 |
19643-19865 |
Sentence |
denotes |
However, our attempts to study BMP-6 protein levels were unsuccessful due to problems with unspecific binding of the anti-BMP-6 antibodies tested, and lack of specific staining in control cells known to express BMP-6 mRNA. |
| T152 |
19643-19865 |
Sentence |
denotes |
However, our attempts to study BMP-6 protein levels were unsuccessful due to problems with unspecific binding of the anti-BMP-6 antibodies tested, and lack of specific staining in control cells known to express BMP-6 mRNA. |
| T7864 |
19866-19924 |
Sentence |
denotes |
In contrast, the recombinant protein was readily detected. |
| T153 |
19866-19924 |
Sentence |
denotes |
In contrast, the recombinant protein was readily detected. |
| T7865 |
19925-20035 |
Sentence |
denotes |
In that respect, few investigators have detected BMP-6 protein in humans, especially in non-pathogenic tissue. |
| T154 |
19925-20035 |
Sentence |
denotes |
In that respect, few investigators have detected BMP-6 protein in humans, especially in non-pathogenic tissue. |
| T7866 |
20036-20245 |
Sentence |
denotes |
The possibility of BMP-6 production in human B-cells is in line with a recent work that reported the production of BMP-6 in mouse B cells, infiltrating the bone marrow of mice with inflammatory arthritis [43]. |
| T155 |
20036-20245 |
Sentence |
denotes |
The possibility of BMP-6 production in human B-cells is in line with a recent work that reported the production of BMP-6 in mouse B cells, infiltrating the bone marrow of mice with inflammatory arthritis [43]. |
| T7867 |
20246-20333 |
Sentence |
denotes |
In this study, a role for BMPs in the inflammatoric process of arthritis was suggested. |
| T156 |
20246-20333 |
Sentence |
denotes |
In this study, a role for BMPs in the inflammatoric process of arthritis was suggested. |
| T7868 |
20334-20436 |
Sentence |
denotes |
The upregulation of the BMP-6-transcripts after IgM-crosslinking is of pathophysiologic interest [12]. |
| T157 |
20334-20436 |
Sentence |
denotes |
The upregulation of the BMP-6-transcripts after IgM-crosslinking is of pathophysiologic interest [12]. |
| T7869 |
20437-20616 |
Sentence |
denotes |
A loss of TGF-β-responsiveness has been suggested to be a critical contribution to malignant transformation [47,48] and similar oncogenic mechanisms have been postulated for BMPs. |
| T158 |
20437-20616 |
Sentence |
denotes |
A loss of TGF-β-responsiveness has been suggested to be a critical contribution to malignant transformation [47,48] and similar oncogenic mechanisms have been postulated for BMPs. |
| T7870 |
20617-20773 |
Sentence |
denotes |
Lines of evidence suggest [49] that at early stages of carcinogenesis, BMP-6 is not a tumour promoter, but suppresses benign and malignant tumour outgrowth. |
| T159 |
20617-20773 |
Sentence |
denotes |
Lines of evidence suggest [49] that at early stages of carcinogenesis, BMP-6 is not a tumour promoter, but suppresses benign and malignant tumour outgrowth. |
| T7871 |
20774-20997 |
Sentence |
denotes |
These findings are in good agreement with previous findings for other TGF-β family members, including TGF-β1 and BMP-4 [50], indicating that cellular context of the BMP target cell might define the various observed effects. |
| T160 |
20774-20997 |
Sentence |
denotes |
These findings are in good agreement with previous findings for other TGF-β family members, including TGF-β1 and BMP-4 [50], indicating that cellular context of the BMP target cell might define the various observed effects. |
| T7872 |
20998-21298 |
Sentence |
denotes |
In contrast to the upregulation of BMP-6 transcript in B cells, we were not able to detect BMP-6 transcripts in human peripheral blood CD4+ or CD8+ T cells (resting or stimulated with anti-CD3 and anti-CD28; data not shown), consistent with the findings in T cell lines [20] and T cells in mice [43]. |
| T161 |
20998-21298 |
Sentence |
denotes |
In contrast to the upregulation of BMP-6 transcript in B cells, we were not able to detect BMP-6 transcripts in human peripheral blood CD4+ or CD8+ T cells (resting or stimulated with anti-CD3 and anti-CD28; data not shown), consistent with the findings in T cell lines [20] and T cells in mice [43]. |
| T7873 |
21299-21449 |
Sentence |
denotes |
Other potential BMP-6 sources for mature B cells in vivo might be other cells of the immune system or tissue with contact to the hematopoietic system. |
| T162 |
21299-21449 |
Sentence |
denotes |
Other potential BMP-6 sources for mature B cells in vivo might be other cells of the immune system or tissue with contact to the hematopoietic system. |
| T7874 |
21450-21546 |
Sentence |
denotes |
One well recognized source for BMP-6 production is the human bone and bone marrow stroma [51,8]. |
| T163 |
21450-21546 |
Sentence |
denotes |
One well recognized source for BMP-6 production is the human bone and bone marrow stroma [51,8]. |
| T7875 |
21547-21726 |
Sentence |
denotes |
Furthermore, it is noteworthy that human umbilical vein endothelial cells (HUVEC) highly express BMP-6 mRNA [52], and vascular endothelium has been reported to produce BMP-6 [53]. |
| T164 |
21547-21726 |
Sentence |
denotes |
Furthermore, it is noteworthy that human umbilical vein endothelial cells (HUVEC) highly express BMP-6 mRNA [52], and vascular endothelium has been reported to produce BMP-6 [53]. |
| T7876 |
21727-21811 |
Sentence |
denotes |
These studies might imply a role for BMP-6 in transendothelial migration of B cells. |
| T165 |
21727-21811 |
Sentence |
denotes |
These studies might imply a role for BMP-6 in transendothelial migration of B cells. |
| T7877 |
21812-21901 |
Sentence |
denotes |
BMP-6 mRNA has been demonstrated in murine macrophage cell lines, but not in humans [54]. |
| T166 |
21812-21901 |
Sentence |
denotes |
BMP-6 mRNA has been demonstrated in murine macrophage cell lines, but not in humans [54]. |
| T7878 |
21902-22060 |
Sentence |
denotes |
In accordance with these findings, other human cell lines of neutrophil and monocytic origin have been described to be negative for the BMP-6 transcript [20]. |
| T167 |
21902-22060 |
Sentence |
denotes |
In accordance with these findings, other human cell lines of neutrophil and monocytic origin have been described to be negative for the BMP-6 transcript [20]. |
| T7879 |
22061-22156 |
Sentence |
denotes |
To our knowledge, there is currently no report about BMP-6 production of human dendritic cells. |
| T168 |
22061-22156 |
Sentence |
denotes |
To our knowledge, there is currently no report about BMP-6 production of human dendritic cells. |
| T169 |
22158-22168 |
Sentence |
denotes |
Conclusion |
| T13400 |
22169-22331 |
Sentence |
denotes |
In conclusion, our results show that BMP-6 induces activation of intracellular Smad signalling in mature human B-cells with consecutive production of Id1 protein. |
| T170 |
22169-22331 |
Sentence |
denotes |
In conclusion, our results show that BMP-6 induces activation of intracellular Smad signalling in mature human B-cells with consecutive production of Id1 protein. |
| T13401 |
22332-22485 |
Sentence |
denotes |
Furthermore, we report that BMP-6 has an antiproliferative effect in B cells stimulated with anti-IgM alone or the combined action of anti-IgM and CD40L. |
| T171 |
22332-22485 |
Sentence |
denotes |
Furthermore, we report that BMP-6 has an antiproliferative effect in B cells stimulated with anti-IgM alone or the combined action of anti-IgM and CD40L. |
| T13402 |
22486-22569 |
Sentence |
denotes |
Additionally, BMP-6 induces cell death in activated memory B cells and Ramos cells. |
| T172 |
22486-22569 |
Sentence |
denotes |
Additionally, BMP-6 induces cell death in activated memory B cells and Ramos cells. |
| T13403 |
22570-22779 |
Sentence |
denotes |
Taken together, these results provide a rationale to further examine the role of BMP-6 signalling in normal B cell biology as well as in pathologic conditions like B cell malignancies and autoimmune disorders. |
| T173 |
22570-22779 |
Sentence |
denotes |
Taken together, these results provide a rationale to further examine the role of BMP-6 signalling in normal B cell biology as well as in pathologic conditions like B cell malignancies and autoimmune disorders. |
| T174 |
22781-22788 |
Sentence |
denotes |
Methods |
| T13700 |
22790-22802 |
Sentence |
denotes |
Cell culture |
| T175 |
22790-22802 |
Sentence |
denotes |
Cell culture |
| T13701 |
22803-22937 |
Sentence |
denotes |
If not specified, all cells were cultured in X-VIVO 15™ (BioWhittaker, Verviers, Belgium) serum-free medium at 37°C and 5% CO2 in air. |
| T176 |
22803-22937 |
Sentence |
denotes |
If not specified, all cells were cultured in X-VIVO 15™ (BioWhittaker, Verviers, Belgium) serum-free medium at 37°C and 5% CO2 in air. |
| T13702 |
22938-23101 |
Sentence |
denotes |
Peripheral blood was provided by the Blood Bank at Buskerud Regional Hospital with formal agreement by the patients, and approval by the regional ethics committee. |
| T177 |
22938-23101 |
Sentence |
denotes |
Peripheral blood was provided by the Blood Bank at Buskerud Regional Hospital with formal agreement by the patients, and approval by the regional ethics committee. |
| T13703 |
23102-23295 |
Sentence |
denotes |
Highly purified resting human B-lymphocytes (CD19+ cells) were isolated from the peripheral blood by rosetting with immunomagnetic beads (Dynabeads M450; Dynal, Oslo, Norway) as described [55]. |
| T178 |
23102-23295 |
Sentence |
denotes |
Highly purified resting human B-lymphocytes (CD19+ cells) were isolated from the peripheral blood by rosetting with immunomagnetic beads (Dynabeads M450; Dynal, Oslo, Norway) as described [55]. |
| T13704 |
23296-23426 |
Sentence |
denotes |
This procedure yields less than 0.5% T cells, 0.1% NK cells, and 0.5% monocytes as judged by indirect immunofluorescence staining. |
| T179 |
23296-23426 |
Sentence |
denotes |
This procedure yields less than 0.5% T cells, 0.1% NK cells, and 0.5% monocytes as judged by indirect immunofluorescence staining. |
| T13705 |
23427-23842 |
Sentence |
denotes |
The following cell lines from human lymphoid malignancies were maintained in RPMI 1640 (PAA Laboratories GmbH, Pasching, Austria) supplemented with 10% foetal bovine serum (FCS), 100 units/ml penicillin G, and 100 units/ml of streptomycin sulphate, but serum-starved for at least four hours and cultured in X-VIVO 15™ when included in experiments: EBV-negative BL cell lines Ramos (ECACC 85030802), HL60 (JCRB0085). |
| T180 |
23427-23842 |
Sentence |
denotes |
The following cell lines from human lymphoid malignancies were maintained in RPMI 1640 (PAA Laboratories GmbH, Pasching, Austria) supplemented with 10% foetal bovine serum (FCS), 100 units/ml penicillin G, and 100 units/ml of streptomycin sulphate, but serum-starved for at least four hours and cultured in X-VIVO 15™ when included in experiments: EBV-negative BL cell lines Ramos (ECACC 85030802), HL60 (JCRB0085). |
| T14146 |
23844-23870 |
Sentence |
denotes |
Growth factors/supplements |
| T181 |
23844-23870 |
Sentence |
denotes |
Growth factors/supplements |
| T14147 |
23871-24385 |
Sentence |
denotes |
The following reagents were used at indicated concentrations: recombinant human (rhu) BMP-6 (1 μg/ml, if not specified otherwise), rhu BMP-RIB/ALK-6/Fc Chimera (5 μg/ml), rhu BMPR-II/Fc Chimera (5 μg/ml), and recombinant mouse Noggin (5 μg/ml) were purchased from R&D Systems (Abingdon, UK); Anti-IgM F(ab)2 fragments of rabbit polyclonal antibodies to human IgM heavy chain (37.5 μg/ml) was obtained from Dako, Copenhagen, Denmark and rhu CD40 ligand (CD40L, 10 ng/ml) was a gift from Immunex Corp. (Seattle, WA). |
| T182 |
23871-24385 |
Sentence |
denotes |
The following reagents were used at indicated concentrations: recombinant human (rhu) BMP-6 (1 μg/ml, if not specified otherwise), rhu BMP-RIB/ALK-6/Fc Chimera (5 μg/ml), rhu BMPR-II/Fc Chimera (5 μg/ml), and recombinant mouse Noggin (5 μg/ml) were purchased from R&D Systems (Abingdon, UK); Anti-IgM F(ab)2 fragments of rabbit polyclonal antibodies to human IgM heavy chain (37.5 μg/ml) was obtained from Dako, Copenhagen, Denmark and rhu CD40 ligand (CD40L, 10 ng/ml) was a gift from Immunex Corp. (Seattle, WA). |
| T14407 |
24387-24455 |
Sentence |
denotes |
Antibodies used for flow cytometric analysis and immunoblot analysis |
| T183 |
24387-24455 |
Sentence |
denotes |
Antibodies used for flow cytometric analysis and immunoblot analysis |
| T14408 |
24456-24597 |
Sentence |
denotes |
Antibodies against the human BMP-receptors Act-RIA, BMP-RIB, BMPR-II, Act-RIIA and Act-RIIb were purchased from R & D Systems (Abingdon, UK). |
| T184 |
24456-24597 |
Sentence |
denotes |
Antibodies against the human BMP-receptors Act-RIA, BMP-RIB, BMPR-II, Act-RIIA and Act-RIIb were purchased from R & D Systems (Abingdon, UK). |
| T14409 |
24598-24910 |
Sentence |
denotes |
Detection of the BMP-6-protein has been tried with the following antibodies: goat polyclonal anti-BMP-6 (Santa Cruz, San Diego, CA, USA), monoclonal mouse anti-BMP-6 and polyclonal goat anti-BMP-6 from R & D Systems (Abingdon, UK), and mouse monoclonal anti-BMP-6 (Chemicon International Inc, Temecula, CA, USA). |
| T185 |
24598-24910 |
Sentence |
denotes |
Detection of the BMP-6-protein has been tried with the following antibodies: goat polyclonal anti-BMP-6 (Santa Cruz, San Diego, CA, USA), monoclonal mouse anti-BMP-6 and polyclonal goat anti-BMP-6 from R & D Systems (Abingdon, UK), and mouse monoclonal anti-BMP-6 (Chemicon International Inc, Temecula, CA, USA). |
| T14410 |
24911-25055 |
Sentence |
denotes |
Characterisation of BMP-signalling pathways was done by use of anti-phospho-Smad1, -5, -and 8 polyclonal antibody (Chemicon, Temecula, CA, USA). |
| T186 |
24911-25055 |
Sentence |
denotes |
Characterisation of BMP-signalling pathways was done by use of anti-phospho-Smad1, -5, -and 8 polyclonal antibody (Chemicon, Temecula, CA, USA). |
| T14411 |
25056-25249 |
Sentence |
denotes |
Expression levels of Id1–3 proteins were detected with polyclonal rabbit antibody and detection was blocked with blocking peptide from Santa Cruz Biotechnology (Santa Cruz, San Diego, CA, USA). |
| T187 |
25056-25249 |
Sentence |
denotes |
Expression levels of Id1–3 proteins were detected with polyclonal rabbit antibody and detection was blocked with blocking peptide from Santa Cruz Biotechnology (Santa Cruz, San Diego, CA, USA). |
| T14412 |
25250-25421 |
Sentence |
denotes |
As secondary antibodies served anti-mouse, anti-goat or anti-rabbit IgG- horseradish peroxidase (HRP) from Dakocytomation AS (Copenhagen, Denmark) for immunoblot analysis. |
| T188 |
25250-25421 |
Sentence |
denotes |
As secondary antibodies served anti-mouse, anti-goat or anti-rabbit IgG- horseradish peroxidase (HRP) from Dakocytomation AS (Copenhagen, Denmark) for immunoblot analysis. |
| T189 |
25422-25455 |
Sentence |
denotes |
Anti-β-actin was from Santa-Cruz. |
| T14413 |
25422-25536 |
Sentence |
denotes |
Anti-β-actin was from Santa-Cruz. From Becton Dickinson (San Jose, CA), we purchased anti-CD19-PE, anti-CD19-FITC. |
| T190 |
25456-25536 |
Sentence |
denotes |
From Becton Dickinson (San Jose, CA), we purchased anti-CD19-PE, anti-CD19-FITC. |
| T14414 |
25537-25716 |
Sentence |
denotes |
The antibodies used for cell sorting were anti-CD19 PC5 from Immunotech SA (Marseille, France) and anti-CD27 PE from Becton Dickinson, Biosciences Pharmingen (San Diego, CA, USA). |
| T191 |
25537-25716 |
Sentence |
denotes |
The antibodies used for cell sorting were anti-CD19 PC5 from Immunotech SA (Marseille, France) and anti-CD27 PE from Becton Dickinson, Biosciences Pharmingen (San Diego, CA, USA). |
| T15100 |
25718-25730 |
Sentence |
denotes |
Cell sorting |
| T192 |
25718-25730 |
Sentence |
denotes |
Cell sorting |
| T15101 |
25731-25951 |
Sentence |
denotes |
Highly purified CD19+CD27- or CD19+CD27+ cells were obtained by staining CD19+ cells with anti-CD27 PE and CD19 PC5 mAbs for 30 minutes at 4°C, followed by washing with PBS and sorting on FACS DiVa from Becton Dickinson. |
| T193 |
25731-25951 |
Sentence |
denotes |
Highly purified CD19+CD27- or CD19+CD27+ cells were obtained by staining CD19+ cells with anti-CD27 PE and CD19 PC5 mAbs for 30 minutes at 4°C, followed by washing with PBS and sorting on FACS DiVa from Becton Dickinson. |
| T15255 |
25953-25974 |
Sentence |
denotes |
Western-blot analysis |
| T194 |
25953-25974 |
Sentence |
denotes |
Western-blot analysis |
| T15256 |
25975-26161 |
Sentence |
denotes |
B cells from peripheral blood or cultured cell-lines were lysed in lysis buffer (glycerol 10%, β-mercaptoethanol 5%, 0.0625 M Tris-HCL [pH 6.8], sodium dodecyl sulphate [SDS] 2.5%w/vol). |
| T195 |
25975-26161 |
Sentence |
denotes |
B cells from peripheral blood or cultured cell-lines were lysed in lysis buffer (glycerol 10%, β-mercaptoethanol 5%, 0.0625 M Tris-HCL [pH 6.8], sodium dodecyl sulphate [SDS] 2.5%w/vol). |
| T15257 |
26162-26355 |
Sentence |
denotes |
Total protein (30–100 μg) from each sample was run on 10% or 12% SDS/polyacrylamide (SDS/PAGE) gels and blotted onto nitrocellulose filters (Protran; Schleicher &Schuell GmbH, Dassel, Germany). |
| T196 |
26162-26355 |
Sentence |
denotes |
Total protein (30–100 μg) from each sample was run on 10% or 12% SDS/polyacrylamide (SDS/PAGE) gels and blotted onto nitrocellulose filters (Protran; Schleicher &Schuell GmbH, Dassel, Germany). |
| T15258 |
26356-26505 |
Sentence |
denotes |
Blocking, washing and incubation of the filters with primary antibodies were done according to the manufacturer's protocols at room temperature (RT). |
| T197 |
26356-26505 |
Sentence |
denotes |
Blocking, washing and incubation of the filters with primary antibodies were done according to the manufacturer's protocols at room temperature (RT). |
| T15259 |
26506-26687 |
Sentence |
denotes |
After washing with TBS/0.1% Tween-20 (TBS-T), the filters were incubated with horseradish peroxidase (HRP) coupled to relevant secondary antibodies (see above) for 60 minutes at RT. |
| T198 |
26506-26687 |
Sentence |
denotes |
After washing with TBS/0.1% Tween-20 (TBS-T), the filters were incubated with horseradish peroxidase (HRP) coupled to relevant secondary antibodies (see above) for 60 minutes at RT. |
| T15260 |
26688-26802 |
Sentence |
denotes |
Enzyme activity was visualised by the enhanced chemiluminescence system, ECL+PLUS (Amersham, Buckinghamshire, UK). |
| T199 |
26688-26802 |
Sentence |
denotes |
Enzyme activity was visualised by the enhanced chemiluminescence system, ECL+PLUS (Amersham, Buckinghamshire, UK). |
| T15261 |
26803-26929 |
Sentence |
denotes |
Densitometric analysis was performed by scanning hyperfilms on a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA). |
| T200 |
26803-26929 |
Sentence |
denotes |
Densitometric analysis was performed by scanning hyperfilms on a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA). |
| T15262 |
26930-27093 |
Sentence |
denotes |
Quantification of Id1, Id2 and Id3 protein was calculated by normalizing the specific protein bands to β-actin using Image Quant 5.5 software (Molecular Dynamics). |
| T201 |
26930-27093 |
Sentence |
denotes |
Quantification of Id1, Id2 and Id3 protein was calculated by normalizing the specific protein bands to β-actin using Image Quant 5.5 software (Molecular Dynamics). |
| T15588 |
27095-27144 |
Sentence |
denotes |
Analysis of BMP-6 messenger RNA (mRNA) expression |
| T202 |
27095-27144 |
Sentence |
denotes |
Analysis of BMP-6 messenger RNA (mRNA) expression |
| T15589 |
27145-27249 |
Sentence |
denotes |
Endogenous expression of the BMP-6 gene was examined by reverse transcription-polymerase chain reaction. |
| T203 |
27145-27249 |
Sentence |
denotes |
Endogenous expression of the BMP-6 gene was examined by reverse transcription-polymerase chain reaction. |
| T15590 |
27250-27402 |
Sentence |
denotes |
Total RNA was isolated using Absolutely RNA™ RT-PCR Miniprep Kit (Stratagene Europe, Amsterdam, Netherland) according to the manufacturers instructions. |
| T204 |
27250-27402 |
Sentence |
denotes |
Total RNA was isolated using Absolutely RNA™ RT-PCR Miniprep Kit (Stratagene Europe, Amsterdam, Netherland) according to the manufacturers instructions. |
| T15591 |
27403-27504 |
Sentence |
denotes |
Quantification of the isolated total RNA was achieved by using spectrophotometric OD260 measurements. |
| T205 |
27403-27504 |
Sentence |
denotes |
Quantification of the isolated total RNA was achieved by using spectrophotometric OD260 measurements. |
| T15592 |
27505-27653 |
Sentence |
denotes |
Equal amounts of RNA were then reverse transcribed to cDNA with TaqMan® Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, U.S.A). |
| T206 |
27505-27653 |
Sentence |
denotes |
Equal amounts of RNA were then reverse transcribed to cDNA with TaqMan® Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, U.S.A). |
| T15593 |
27654-27762 |
Sentence |
denotes |
To measure mRNA expression of BMP6, Id1–Id4 and PGK1 PCR were carried out with TaqMan® universal master mix. |
| T207 |
27654-27762 |
Sentence |
denotes |
To measure mRNA expression of BMP6, Id1–Id4 and PGK1 PCR were carried out with TaqMan® universal master mix. |
| T15594 |
27763-27836 |
Sentence |
denotes |
Primers and probes were provided by Assay-on-Demand (Applied Biosystems). |
| T208 |
27763-27836 |
Sentence |
denotes |
Primers and probes were provided by Assay-on-Demand (Applied Biosystems). |
| T15595 |
27837-27918 |
Sentence |
denotes |
PCR reactions were carried out in a final volume of 25 μl (BMP-6) or 20 μl (ID1). |
| T209 |
27837-27918 |
Sentence |
denotes |
PCR reactions were carried out in a final volume of 25 μl (BMP-6) or 20 μl (ID1). |
| T15596 |
27919-28001 |
Sentence |
denotes |
The cDNA added to each reaction was equivalent to the input of 20 ng of total RNA. |
| T210 |
27919-28001 |
Sentence |
denotes |
The cDNA added to each reaction was equivalent to the input of 20 ng of total RNA. |
| T15597 |
28002-28173 |
Sentence |
denotes |
The gene expression was quantified using the standard curve method (BMP6), or the comparative CT method (Id1) as described in ABI7700 User Bulletin 2 (Applied Biosystems). |
| T211 |
28002-28173 |
Sentence |
denotes |
The gene expression was quantified using the standard curve method (BMP6), or the comparative CT method (Id1) as described in ABI7700 User Bulletin 2 (Applied Biosystems). |
| T15598 |
28174-28241 |
Sentence |
denotes |
The expression was then normalized to the expression level of PGK1. |
| T212 |
28174-28241 |
Sentence |
denotes |
The expression was then normalized to the expression level of PGK1. |
| T15599 |
28242-28352 |
Sentence |
denotes |
PGK1 was chosen, because it has been shown to have low expression variability among lymphocyte specimens [56]. |
| T213 |
28242-28352 |
Sentence |
denotes |
PGK1 was chosen, because it has been shown to have low expression variability among lymphocyte specimens [56]. |
| T15600 |
28353-28440 |
Sentence |
denotes |
Expression levels in B cells were then related to the expression levels in Ramos cells. |
| T214 |
28353-28440 |
Sentence |
denotes |
Expression levels in B cells were then related to the expression levels in Ramos cells. |
| T16230 |
28442-28460 |
Sentence |
denotes |
Cell proliferation |
| T215 |
28442-28460 |
Sentence |
denotes |
Cell proliferation |
| T16231 |
28461-28617 |
Sentence |
denotes |
For estimation of DNA synthesis, CD19+ cells (7.5 × 104 cells/0.2 ml) or Ramos cells (1 × 104 cells/0.2 ml) were cultured in triplicate in microtiter wells. |
| T216 |
28461-28617 |
Sentence |
denotes |
For estimation of DNA synthesis, CD19+ cells (7.5 × 104 cells/0.2 ml) or Ramos cells (1 × 104 cells/0.2 ml) were cultured in triplicate in microtiter wells. |
| T16232 |
28618-28742 |
Sentence |
denotes |
The cells were pulsed with 3.7 × 104Bq [3H]thymidine (Amersham, Buckinghamshire, UK) for the last 16 h of a 72-h incubation. |
| T217 |
28618-28742 |
Sentence |
denotes |
The cells were pulsed with 3.7 × 104Bq [3H]thymidine (Amersham, Buckinghamshire, UK) for the last 16 h of a 72-h incubation. |
| T16233 |
28743-28980 |
Sentence |
denotes |
The cells were harvested using an automated cell harvester (Packard Instrument Company, Meriden, CT, USA) and [3H]thymidine incorporation was determined in a scintillation counter (TopCount, Packard Instrument Company Inc., Meriden, CT). |
| T218 |
28743-28980 |
Sentence |
denotes |
The cells were harvested using an automated cell harvester (Packard Instrument Company, Meriden, CT, USA) and [3H]thymidine incorporation was determined in a scintillation counter (TopCount, Packard Instrument Company Inc., Meriden, CT). |
| T16473 |
28982-29009 |
Sentence |
denotes |
Determination of cell death |
| T219 |
28982-29009 |
Sentence |
denotes |
Determination of cell death |
| T16474 |
29010-29180 |
Sentence |
denotes |
Cell death was measured by vital dye exclusion test by staining cells with 5 μg/ml propidium iodide ([PI]; Calbiochem Corp.; La Jolla, CA; 5 mg/ml) for one minute on ice. |
| T220 |
29010-29180 |
Sentence |
denotes |
Cell death was measured by vital dye exclusion test by staining cells with 5 μg/ml propidium iodide ([PI]; Calbiochem Corp.; La Jolla, CA; 5 mg/ml) for one minute on ice. |
| T16475 |
29181-29257 |
Sentence |
denotes |
At least 1,000 cells per sample were run on a BD FACSCalibur flow cytometer. |
| T221 |
29181-29257 |
Sentence |
denotes |
At least 1,000 cells per sample were run on a BD FACSCalibur flow cytometer. |
| T16606 |
29259-29279 |
Sentence |
denotes |
Statistical analysis |
| T222 |
29259-29279 |
Sentence |
denotes |
Statistical analysis |
| T16607 |
29280-29471 |
Sentence |
denotes |
The statistical significance of differences between groups was determined using the paired two-tailed Wilcoxon nonparametric test, by applying SPSS10.1 software (SPSS Inc., Chicago, IL, USA). |
| T223 |
29280-29471 |
Sentence |
denotes |
The statistical significance of differences between groups was determined using the paired two-tailed Wilcoxon nonparametric test, by applying SPSS10.1 software (SPSS Inc., Chicago, IL, USA). |
| T16608 |
29472-29524 |
Sentence |
denotes |
P values less than 0.05 were considered significant. |
| T224 |
29472-29524 |
Sentence |
denotes |
P values less than 0.05 were considered significant. |
| T225 |
29526-29547 |
Sentence |
denotes |
List of abbreviations |
| T226 |
29548-29579 |
Sentence |
denotes |
BMP, Bone morphogenetic protein |
| T227 |
29580-29616 |
Sentence |
denotes |
DLBCL, diffuse large B cell lymphoma |
| T228 |
29617-29645 |
Sentence |
denotes |
Id, inhibitor of dna binding |
| T229 |
29646-29765 |
Sentence |
denotes |
Smad, the name Smad originates from the Drosophila protein, MAD and the Caenorhabditis elegans proteins, sma-2, 3 and 4 |
| T230 |
29766-29820 |
Sentence |
denotes |
STAT, signal transducer and activator of transcription |
| T231 |
29822-29844 |
Sentence |
denotes |
Authors' contributions |
| T232 |
29845-29918 |
Sentence |
denotes |
CK designed and conducted experiments, oversaw research, and wrote paper. |
| T233 |
29919-29976 |
Sentence |
denotes |
EAS designed and conducted experiments, oversaw research. |
| T234 |
29977-30034 |
Sentence |
denotes |
MEH designed and conducted experiments, oversaw research. |
| T235 |
30035-30073 |
Sentence |
denotes |
LF designed and conducted experiments. |
| T236 |
30074-30134 |
Sentence |
denotes |
EBS designed experiments, oversaw research, and wrote paper. |
| T237 |
30135-30209 |
Sentence |
denotes |
JHM designed and conducted experiments, oversaw research, and wrote paper. |